6-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine

Catalog No. :
ACWDIT184
CAS No. :
1555334-06-9
Molecular Formula :
C7H11N3
Molecular Weight :
137.19

IUPAC Name:6-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine

6-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$223.00Login to see priceIn stockInquiry
250mg95%$371.00Login to see priceIn stockInquiry
500mg95%$618.00Login to see priceIn stockInquiry
1g95%$927.00Login to see priceIn stockInquiry
5g95%$2781.00Login to see priceIn stockInquiry
10g95%$4635.00Login to see priceIn stockInquiry
25g95%$9270.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine
IUPAC Name6-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine
MDL No.MFCD28604897
Molecular FormulaC7H11N3
Molecular Weight137.19
SMILESCC1CNC2=CC=NN2C1
InChI KeyZDLMVHIUOSXNGN-UHFFFAOYSA-N
Synonym6-Methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine | 1555334-06-9 | SCHEMBL24439554 | EN300-374222 | F86039
CAS No.1555334-06-9
PubChem CID136300215

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWDIT184 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWDIT184 route product structure diagram
    ACWDIT1841555334-06-9 In Stock
Inquiry

2. ACWDIT184 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWDIT184 route product structure diagram
    ACWDIT1841555334-06-9 In Stock
Inquiry

Comments (0)